SHILPAMED

Shilpa Medicare, established in 1987 and headquartered in Raichur, Karnataka, operates in the pharmaceutical industry. The company manufactures niche active pharmaceutical ingredients (APIs), intermediates, and formulations. Its product portfolio includes 16 injectable dosage forms and 19 oral solid dosage forms marketed under Shilpa Medicare Limited (SML), along with 13 formulations developed by its wholly owned subsidiary, Shilpa Therapeutics. The business segments encompass APIs, intermediates, formulations, contract research and manufacturing services, oncology, non-oncology, biologics, and emerging specialty areas such as Antibody Drug Conjugates (ADCs). Shilpa Medicare has evolved into a specialist drug delivery entity with a diversified presence in these segments. The company maintains a significant regulatory presence across more than 50 countries, including the United States, the European Union, and various emerging markets.